REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuromedica S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neuromedica S.A.S. Profile Updated: December 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neuromedica S.A.S. is based in Colombia. The head office is in Medellin. It operates in the Ambulatory Health Care Services sector. The company was established on February 07, 2014. There are currently 904 (2024) people employed by Neuromedica S.A.S.. There was a net sales revenue increase of 24.26% reported in Neuromedica S.A.S.’s latest financial highlights for 2023. During that time, Neuromedica S.A.S.’s total assets decreased by 16.13%.

Headquarters
Carrera 49 14 30 Piso 3
Medellin; Antioquia;

Contact Details: Purchase the Neuromedica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neuromedica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Neuromedica S.A.S. report to view the information.
Incorporation Date:
February 07, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Neuromedica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
24.26%
Total operating revenue
24.26%
Operating profit (EBIT)
11.35%
EBITDA
14.41%
Net Profit (Loss) for the Period
N/A
Total assets
-16.13%
Total equity
176.73%
Operating Profit Margin (ROS)
3.56%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-349.23%
Quick Ratio
0.2%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?